IL-19 is a novel component of the pathogenetic IL-23/IL-17 cascade in psoriasis

被引：0
|
作者：
Witte, E. [1 ,2 ]
Kokolakis, G. [1 ,2 ]
Witte, K. [1 ,2 ]
Philipp, S. [1 ,2 ]
Doecke, W. [3 ]
Babel, N. [4 ,5 ]
Wittig, B. [6 ]
Warszawska, K. [1 ]
Kurek, A. [1 ,2 ]
Erdmann-Keding, M. [1 ,2 ]
Kunz, S. [1 ,2 ]
Asadullah, K. [3 ]
Kadin, M. [7 ]
Volk, H. [8 ]
Sterry, W. [9 ]
Wolk, K. [1 ,2 ]
Sabat, R. [1 ,2 ]
机构：
[1] Univ Hosp Charit, Interdisciplinary Grp Mol Immunopathol, D-10117 Berlin, Germany
[2] Univ Hosp Charit, Psoriasis Res & Treatment Ctr, D-10117 Berlin, Germany
[3] Bayer Pharma AG, Global Biomarker, Berlin, Germany
[4] Univ Hosp Charit, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany
[5] Univ Hosp Charit, Dept Nephrol, Berlin, Germany
[6] Univ Hosp Charit, Med Clin 1, Berlin, Germany
[7] Boston Univ, Sch Med, Roger Williams Med Ctr, Dept Dermatol & Skin Surg, Providence, RI USA
[8] Univ Hosp Charit, Inst Med Immunol, Berlin, Germany
[9] Univ Hosp Charit, Dept Dermatol & Allergy, Berlin, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2014年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E20 / E20
页数：1
相关论文
共 50 条
  • [1] IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
    Witte, Ellen
    Kokolakis, Georgios
    Witte, Katrin
    Philipp, Sandra
    Doecke, Wolf-Dietrich
    Babel, Nina
    Wittig, Bianca M.
    Warszawska, Katarzyna
    Kurek, Agata
    Erdmann-Keding, Magdalena
    Kunz, Stefanie
    Asadullah, Khusru
    Kadin, Marshall E.
    Volk, Hans-Dieter
    Sterry, Wolfram
    Wolk, Kerstin
    Sabat, Robert
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (11) : 2757 - 2767
  • [2] Interleukin (IL)-19 is a novel component of the pathogenetic IL-23/IL-17 pathway in psoriasis
    Witte, E.
    Kokolakis, G.
    Witte, K.
    Philipp, S.
    Babel, N.
    Wittig, B. M.
    Erdmann-Keding, M.
    Kadin, M. E.
    Volk, H. -D.
    Sterry, W.
    Wolk, K.
    Sabat, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E155 - E155
  • [3] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [4] Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis
    Wang, Xinwei
    Lin, Zhiming
    Wei, Qiujing
    Jiang, Yingjuan
    Gu, Jieruo
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (11) : 1343 - 1347
  • [5] Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis
    Xinwei Wang
    Zhiming Lin
    Qiujing Wei
    Yingjuan Jiang
    Jieruo Gu
    Rheumatology International, 2009, 29 : 1343 - 1347
  • [6] IL-23 and IL-17 in tuberculosis
    Khader, Shabaana A.
    Cooper, Andrea M.
    CYTOKINE, 2008, 41 (02) : 79 - 83
  • [7] IL-23/IL-17 axis in rheumatoid synovium: IL-23 is a determinant of svnovial IL-17 production
    Stamp, Lisa K.
    Easson, Andrea
    Higton, John
    Hessian, Paul A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S187 - S188
  • [8] New Biologics in Psoriasis: An Update on IL-23 and IL-17 Inhibitors
    Dong, Joanna
    Goldenberg, Gary
    CUTIS, 2017, 99 (02): : 123 - 127
  • [9] Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
    Hawkes, Jason E.
    Yan, Bernice Y.
    Chan, Tom C.
    Krueger, James G.
    JOURNAL OF IMMUNOLOGY, 2018, 201 (06): : 1605 - 1613
  • [10] The IL-23 to IL-17 cascade in inflammation-related cancers
    Wang, K.
    Karin, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : S87 - S90
12345